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Understanding of sequence diversity is the cornerstone of analysis of genetic disorders, population
genetics, and evolutionary biology. Here, we present an update of our sequencing set to 15,220 Icelanders
who we sequenced to an average genome-wide coverage of 34X. We identiﬁed 39,020,168 autosomal
variants passing GATK ﬁlters: 31,079,378 SNPs and 7,940,790 indels. Calling de novo mutations (DNMs) is a
formidable challenge given the high false positive rate in sequencing datasets relative to the mutation rate.
Here we addressed this issue by using segregation of alleles in three-generation families. Using this
transmission assay, we controlled the false positive rate and identiﬁed 108,778 high quality DNMs.
Furthermore, we used our extended family structure and read pair tracing of DNMs to a panel of phased
SNPs, to determine the parent of origin of 42,961 DNMs.
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Background & Summary
Characterization of genetic diversity is of paramount importance to population genetics. Advances in
sequencing technologies have been instrumental in the creation of whole-genome sequencing data sets on
the population level1–5. Sequencing data augmented with chip-typed samples have proven a valuable
approach in genome-wide association studies, by combining the low cost of chip typing with the
comprehensive characterization of sequence diversity via whole-genome sequencing1–3,5. In contrast, the
analysis of DNMs and other recent mutations requires the sequencing of families in which these recent
mutations have occurred.
DNM detection is hampered by the fact that they are typically only observed in very few individuals
(most often a single individual) and sequencing unrelated individuals is of limited value. Furthermore,
analysis of singletons and DNMs is complicated since current sequencing technologies and calling
algorithms identify a non-trivial number of false-positives6. The analysis of rare variants requires more
extensive quality control than the analysis of common variants.
Families with well understood inheritance patterns provide useful tools for this purpose, such as
monozygotic twin concordance and the transmission of DNM alleles to offspring of probands in three-
generation families. These methods provide genome-wide validation assays with no ascertainment
beyond the family relationships of the probands. A useful feature of the Icelandic population are
comprehensive genealogical records going back to 1,600 (and in some instances back to 740). The
deCODE genetics genealogical databases currently includes records of 819,410 Icelanders7.
Here, we have sequenced 12,803 Icelanders in addition to the previously described 2,417 (ref. 7) to an
average 34X coverage. This sequencing effort resulted in 39,020,168 autosomal variants passing GATK
ﬁlters and for the entire variant set we were able to impute 37,127,995 variants into a set of 151,677 chip
genotyped Icelanders.
We particularly focused on obtaining quality DNM calls. We calibrated our DNM calling with
segregation of alleles in three-generation families, and subsequently validated our DNM calls with
concordance among monozygotic twins. This resulted in data set of 108,778 high quality DNM calls, of
which we were able to determine the parent of origin for 42,961 by observing their segregation in three-
generation families and read tracing DNMS with phased and imputed variants.
Methods
The following methods are an extension of those reported by Jónsson et al.8
Chip genotyping and long range phasing
We performed chip genotyping on 47,555 additional individuals relative to the set presented by
Gudbjartsson et al.7. We used the OmniExpress24 chip for the majority of the samples (33,710; Table 1).
This update resulted in a set of 151,677 individuals with chip genotypes. Finally, we long range phased
(LRP) the data set using the algorithm described by Kong et al.9, resulting in a panel of 151,677
individuals with LRP chip genotypes.
Preparation of samples for whole-genome sequencing
DNA was derived from two sample types: buccal swab and whole blood. Three different sample
preparation kits from Illumina were employed: TruSeq DNA (Method A), TruSeq Nano (Method B) and
TruSeq PCR-Free (Method C). Samples were prepared for sequencing according to the manufacturers’
instructions (Illumina). In short, either 50 ng (Method B) or 1 μg (Methods A and C) of genomic DNA,
isolated from either frozen blood samples or buccal swabs, was fragmented to a mean target size of
300–400 bp using a Covaris E220 instrument. End repair, generating blunt ended fragments was
performed followed by size selection using different ratios of AMPure XP magnetic puriﬁcation beads.
3′-Adenylation and ligation of indexed sequencing adaptors containing a T nucleotide overhang was
performed, followed either by AMPure puriﬁcation (Method C) alone or puriﬁcation followed by PCR
enrichment (10 cycles) using appropriate primers (Methods A and B). The quality and concentration of
all sequencing libraries was assessed using either the Agilent 2,100 Bioanalyzer (12-samples) or the
LabChip GX (96-samples) instrument from Perkin Elmer. Sequencing libraries were diluted and stored at
−20 °C. Further quality control of sequencing libraries was done by multiplexing and pooling either 24 or
96 samples and sequencing each pool on an Illumina MiSeq instrument to assess optimal cluster
densities, library insert size, duplication rates and library diversities. All steps in the workﬂow were
monitored using an in-house laboratory information management system (LIMS) with barcode tracking
of all samples and reagents.
DNA whole genome sequencing
Sequencing libraries were hybridized to the surface of paired-end (PE) ﬂowcells using the Illumina cBot.
Paired-end sequencing-by-synthesis (SBS) was performed on Illumina sequencers, including GAIIx,
HiSeq 2,000/2,500 or HiSeq X instruments, respectively. Read lengths depended on the instrument and/or
sequencing kit being employed and varied from 2× 76 cycles to 2 × 150 cycles of incorporation and
imaging. Real-time analysis involved conversion of image data to base-calling in real-time. The largest
number of samples (approximately 12,000) were sequenced on HiSeq X instruments with read lengths of
2 × 150 cycles, using either v1 or v2 ﬂowcells and sequencing chemistries, respectively (Table 2).
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Reference
The reference sequences used to map reads was the human genome assembly GRCh38, not including
alternate assemblies (GCA_000001405.15_GRCh38_no_alt_analysis_set.fna) in addition to sequences
determined to represent common contaminants in our sequencing pipeline. These sequences are the
sequences of the bacteriophage PhiX (Enterobacteria_phage_phiX174_sensu_lato_uid14015/NC_001422.
fna), the bacteria Ralstonia Pickettii (Ralstonia_pickettii_12D_uid58859) and two sequences from the
human microbiome (Coprobacillus_D7_uid32495/NZ_EQ999972.fna, Coprobacillus_D7_uid32495/
NZ_EQ999922.fna).
Alignment of sequences
We aligned the raw sequences against the reference described in the previous section with BWA version
0.7.10 mem10. The sequences in the BAM ﬁles were realigned around indels with GenomeAnalysisTK-
Lite/2.3.9 (ref. 11) using a public set of known indels and a set of indels previously discovered in the
Icelandic data. We marked PCR duplicates with Picard tools 1.117.
Filtering of BAM ﬁles
We organized the sequencing data of each individual into one BAM ﬁle per lane on the ﬂowcell. Much of
the sequencing data generated for each individual prior to the HiSeqX machines derived from multiple
lanes. In contrast, the sequencing data generated for each individual from HiSeqX machines largely
derives from single lanes. In the following, we will refer to BAM ﬁles created before and after the merging
per individual as BM- and AM-BAM ﬁles, respectively.
We performed a pileup using samtools BM-BAM ﬁles at all sites where the sample is homozygous
according to their chip genotypes. We combined these pilups for each sample and calculated a mismatch
rate as the number of bases not matching the chip genotype divided by the number of chip typed bases.
We exlucded BM-BAM ﬁles with mismatch rates above 2% from the analysis.
Name Description Nr. of SNPs Current Overlap
OmniExpress HumanOmniExpress 725,095 49,482 35,847
OmniExpress24 HumanOmniExpress-24 714,758 33,894 184
HumanHap 300 Illumina HumanHap 317 K SNP Chip 317,870 22,429 22,394
HumanHapCNV 370 Merge of HumanHap300 and HumanCNV chips 371,900 14,138 14,085
Human Omni1 1M SNP Chip redesigned, 500 K diff versus normal 1 M 1,137,466 10,859 10,809
OmniExpPlus DECODE 706,534 9,725 9,708
Omni2.5–8 HumanOmni2.5–8 2,379,855 3,948 3,941
OmniExpMulti HumanOmniExp-12v1MultiUse 730,525 2,808 2,799
HumanOmni2.5 HumanOmni2.5 2,443,177 2,352 2,340
HumanHap 1M Illumina HumanHap 1M SNP Chip 1,136,004 1,267 1,261
Omni5 HumanOmni5-4v1 4,301,332 661 658
HumanHap 610 Illumina Human610-Quad v1 SNP Chip 620,901 646 640
Omni2.5Multi HumanOmni2.5-4v1-Multi_D 2,443,177 400 399
Human660W Human660W 655,214 22 1
Table 1. Summary of the genotyping chips used for the individuals in the LRP panel. The overlap
column corresponds to the numbers of genotyping chips used for individuals that were present in the LRP set
of Gudbjartsson et al.1 The Nr. of SNPs column is the average number of markers across all minor versions of
the chip type.
HiSeq X HiSeq X2 HiSeq 2000 HiSeq 2500 GAIIx HiSeq
TrueSeq DNA 6,603 452 107 0 0 0
TruSeq Nano 0 5,310 1,054 124 0 0
TruSeq PCR-Free 0 0 6 0 21 1
Unknown 0 0 4 1 0 0
Table 2. The pairwise co-occurrences of sample preparation and ﬂow-cell type. This table is based on
the subset of individuals sequenced and used for genotyping by sequencing in this study. Note that the same
individual can appear multiple times if sequenced more than once. The sample preparation methods are
described in the ‘Preparation of samples for whole genome sequencing’ section. This table is reproduced from
Supplementary Table 18 from Jónsson et al.8.
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We merged BM-BAM ﬁles into single AM-BAM ﬁles based on unique individual and sample type
source combinations. The total number of AM-BAM ﬁles, prior to the subsequent quality ﬁltering was
17,326. For contamination estimation, we used number and fraction of read pairs between pairs of
heterzygote SNP markers supporting three or more haplotypes as a surrogate for the contamination level.
We omitted AM-BAM ﬁles from subsequent analysis where more than 0.1% of SNP pairs had two or
more reads supporting the third haplotype.
We removed AM-BAM ﬁles from the analysis if any of the underlying BM-BAM ﬁles failed any of the
following criteria:
● Mean base quality o25
● Percent marked duplicate > 50
● Mean N per read >30
● Percent mapping quality below 20 >11
● Percent reads unmapped > 40
● Percent both reads in a pair unmapped > 40
● Percent ﬁrst read in a pair unmapped > 40
● Percent second read in a pair unmapped > 40
Furthermore, if there were two sample types available for the individual AM-BAM ﬁle, we used the
whole-blood AM-BAM ﬁle.
The ﬁnal set of AM- and BM-BAM ﬁles used for the genotyping by sequencing consisted of 15,220
and 27,817 ﬁles, respectively. The set of AM-BAM ﬁles derive from 14,101 blood and 1,119 buccal swab
samples. The co-occurrences of ﬂowcell and machine types for BM-BAM ﬁles are listed in Table 3. The
counts of machine and ﬂowcell combinations for the AM-BAM ﬁles are listed in Table 4.
Variant calling
We applied a ﬁltering step after merging the alignments and before the variant calling. We required the
alignment to contain at least 45 matching bases (not necessarily consecutive) and removed parts of reads
extending from template and into the adapter. For the adapter removal, we hard clip bases from the
forward read extending further than the rightmost alignment of the reverse read and vice versa for the
bases in the reverse read extending further than the leftmost alignment in the forward read.
Subsequently, we merge BAM ﬁles across all individuals in segments of 50,000 bases using SAMtools
(version 1.3)12. These merged BAM ﬁles were used as input to GATK uniﬁed genotype caller11, resulting
in a pooled genotype calling of 15,220 individuals. This resulted in 39,020,168 autosomal variants that
passed the GATK recommended ﬁlters1, of which 31,079,378 and 7,940,790 were SNPs and indels,
respectively (Table 5). Of the 15,220 individuals used for the sequence genotyping, we restricted the DNM
identiﬁcation to 14,688 individuals with over 20x coverage.
Variant phasing
To improve genotype quality and to phase genotypes, we used an iterative algorithm based on the
IMPUTE HMM model13 and LRP haplotypes1,7. This method is based on the principle that individuals
that share haplotypes spanning the marker of interest are more likely to carry the same allele at the
marker on the background of the shared haplotypes. For example, a pair of carriers of a rare sequence
variant that share a haplotype are more likely to carry the rare variant on the shared haplotype than the
two haplotypes that they do not share.
Variant imputation
Variants were imputed based on the IMPUTE HMM model13 as previously described1,7, where chip
genotyped individuals that share haplotypes with individuals in the set of sequenced individuals (the
training set) are imputed to have the alleles on the background of the shared haplotypes.
Genotype imputation information
The informativeness of genotype imputation was estimated by the ratio of the variance of imputed
expected allele counts and the variance of the actual allele counts:
VarðE θ9chipdata Þ
VarðθÞ ;
GAIIx HiSeq HiSeq 2000 HiSeq 2500 HiSeq X HiSeq X2
GAIIx 8,309 0 0 0 0 0
HiSeq 0 1,115 4,946 136 0 0
HiSeq X 0 0 0 0 6,606 6,705
Table 3. The co-occurrences of ﬂowcell and machine type for the BM-BAM ﬁles. The rows and columns
correspond to the machine and ﬂowcell types, respectively.
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where θ∈ {0, 1} is the allele count. Var(E(θ/chip data)) was estimated by the observed variance of the
imputed expected counts and Var(θ) was estimated by p(1− p), where p is the allele frequency. The
number of sequence variants with imputation information greater than 0.8 per variant type is listed in
Table 5.
Extraction of de novo candidates
A schematic overview of the DNM identiﬁcation procedure is shown in Fig. 1. Here we deﬁne allelic
balance as the fraction of reads supporting the alternative allele out of the reads supporting the reference
and alternative alleles combined. We used the genotype from GATK to deﬁne possible carriers. We deﬁne
likely carriers of a DNM as those that meet the following requirements: read depth over 12, allele balance
deviation from 0.5 less than 0.25 and genotype likelihood difference greater than 20 between the highest
and second-highest scoring genotype (GQ). We restricted our DNM analysis to the primary assembly of
the autosomes and chromosome X (hg38).
We extracted DNM candidates from the variants satisfying the following criteria:
● The proband must be an alternative allele carrier.
● For homozygous alternative allele carriers, we only consider candidates with 1 or no reads supporting
the reference allele
● Minimum depth in the parent of 12 reads for the autosomes and 6 reads for the X chromosome
in males
● No more than one read supporting the alternative allele in the parent
● Maximum allelic balance for parent of 0.05
● Minimum depth of 12 reads for proband
● Minimum allelic balance for proband of 0.15
● Maximum of 10 possible and 3 likely carriers beyond the descendants of the parent-pair
● Maximum of 10% average soft clipping per read covering the DNM candidate
Machine Frequency Flowcell Frequency
HiSeq X 12,091 HiSeq X 6,439
GAIIx-HiSeq 1,228 HiSeq X2 5,648
HiSeq 719 GAIIx-HiSeq 2000 997
GAIIx-HiSeq-HiSeq X 473 HiSeq 2000 599
GAIIx-HiSeq X 432 GAIIx-HiSeq X2 432
GAIIx 253 GAIIx-HiSeq-HiSeq X2 271
HiSeq-HiSeq X 24 GAIIx 253
GAIIx-HiSeq 2000-HiSeq X2 202
GAIIx-HiSeq 139
HiSeq 2000-HiSeq 2500 94
GAIIx-HiSeq-HiSeq 2000 92
HiSeq 2500 23
HiSeq 2000-HiSeq X2 10
HiSeq 2000-HiSeq X 8
HiSeq-HiSeq X2 6
HiSeq X-HiSeq X2 4
HiSeq 2
HiSeq-HiSeq 2000 1
Table 4. The frequencies of ﬂowcell and machine combinations for the AM-BAM ﬁles
Variant type Allele Total GATK-P Phase-P Imputation-P
Indel Biallelic 5,962,773 3,510,962 4,009,176 3,235,133
Indel Non-biallelic 7,085,563 4,429,828 5,462,957 3,619,729
SNP Biallelic 69,663,011 30,518,223 35,631,803 29,319,382
SNP Non-biallelic 3,406,010 561,155 1,679,332 953,751
Total Biallelic 75,625,784 34,029,185 39,640,979 32,554,515
Total Non-biallelic 10,491,573 4,990,983 7,142,289 4,573,480
Table 5. Summary of the variants. The columns GATK-P, Phase-P (>0.8) and Imputation-P (>0.8)
correspond to number of variants passing the respective ﬁlters. Multi allelic variants were dichtomized.
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Furthermore, we removed probands from the DNM analysis with more than: 10% average soft
clipping per read, 1.5% average fraction of Ns in the read alignment and 300 DNM candidates. This
removed 15 probands, of which two are three-generation probands and one was a monozygotic twin
proband.
QC-ﬁltering using transmission in three-generation families
The DNM candidates identiﬁed in three-generation family probands were used to tune the DNM calling
by tracing the transmission of alleles to offspring of the proband. We interpret discrepancy between
haplotype sharing and segregation of a DNM as an indication that it is not present in the germline. More
speciﬁcally, we dichotomized the DNMs according to whether they are consistent with haplotype
transmission from the proband to his or her offspring. We restricted to DNMs where two or more
offspring share distinct haplotypes from the proband in three-generation families.
We imposed a biological constraint on the DNM candidates on the X chromosome, i.e., male carriers
must be homozygous for the alternative allele, otherwise we consider it inconsistent. To avoid
inconsistency calls due to low quality genotypes in the offspring, we treated genotype calls of the offspring
as missing if they do not meet the following requirements: at least 2 reads supporting an alternative allele,
allelic balance over or equal to 0.1 and depth over or equal to 10 reads.
This evaluation of the DNM candidates gave us a binary outcome y, that we incorporate into the
following Generalized Additive Model (GAM)
Y∼sðPsrobandallelicbalanceÞ þ sðoxoGFoxoGmetricÞ þ sðTrioNPOSSÞ þ gatkfilter:
s() denotes a smooth term and the covariates are described in the following listing:
● Proband_allelic_balance, allelic balance of the proband.
● oxoG_FoxoG_metric, 0 for non-C>A substitutions and for C>A substitutions it measures the strand
speciﬁc afﬁnity of the C>A variant, as deﬁned by Costello et al.14.
● Trio_NPOSS, The number of possible carriers of the DNM allele beyond the descendants of the
proband’s parents. For example, if there are 11 possible carriers of the variant unrelated to the proband
Trio_NPOSS is 11.
● gatk_ﬁlter, this is a binary covariate dichotomizing whether the variant passes variant ﬁlters
recommended by GATK best practices.
Figure 1. Schematic overview of the DNM characterization.
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Using the ﬁtted model, we predicted response for all DNM candidates. We used response strictly
greater than 0.8 to deﬁne high-quality DNMs (Fig. 2).
Phasing of de novo mutations
We used two complementary approaches to phasing DNMs, i.e., using haplotype sharing in three-
generation families and read pair tracing DNMs with phased variants. In the former approach, we
determined the parent of origin as in our previous analysis15. For example, if an offspring of the proband
is a carrier of the DNM and carries the paternal chromosome of the proband, we assigned the mutation to
the father. Conversely, if the offspring is not a DNM allele carrier then we would assign the DNM to the
mother. If there were conﬂicting phase assignments among multiple siblings, we treated the DNM as
unphased. We restricted the haplotype sharing analysis to segments of genetic length of at least 0.8 cM
and with 200 consecutive markers present in the LRP panel.
In the latter approach, we used the phased and imputed panel of markers as described above to serve
as a reference panel. We counted the number of read pairs traversing each biallelic combination between
the DNM variant and the neighboring imputed and phased variants. We also recorded the number of
read pairs supporting three or more haplotypes and reads not consistent with any of the biallelic
combinations. We aggregated these numbers of read pairs per parent pair and DNM site. Using this
summary, we phased DNMs by assigning the DNM allele to the parental chromosome with the read
support. We only considered DNMs with read support for only one parent-of-origin. Finally, we
aggregated the phase information from both methods into a consensus phase. Of the 4,566 DNMs that
were phased by both methods, we excluded 53 that were phased inconsistently (Table 6).
Code availability
We used publicly available software (URLs listed below) in conjunction with the above described
algorithms in the sequencing processing pipeline (sections Variant phasing and Variant imputation).
● BWA 0.7.10 mem, https://github.com/lh3/bwa
● GenomeAnalysisTKLite 2.3.9, https://github.com/broadgsa/gatk/ https://github.com/broadgsa/gatk-
protected/
● Picard tools 1.117, https://broadinstitute.github.io/picard/
● SAMtools 1.3, http://samtools.github.io/
● Bedtools v2.25.0-76-g5e7c696z, https://github.com/arq5x/bedtools2/
Phased set Counts Fraction of the DNMs
Three gen. imputation 15,746 0.145
Read pair tracing 31,834 0.293
Phased by both methods 4,566 0.0420
Phased by both methods, discordant (1.16%) 53 0.000487
Consensus approach 42,961 0.395
Table 6. Summary of the phased DNMs.
Figure 2. The GAM model predicted response for all DNM candidates. The red line corresponds to the 0.8
GAM response requirement for the high quality DNMs.
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Data Records
We have deposited two data records to the European Variation Archive (EVA), the 39,020,168 sequence
variants passing the GATK ﬁlters in 15,220 sequenced Icelanders (Data Citation 1) and the 108,778 high
quality DNMs (Data Citation 2) annotated with phase information.
Technical Validation
As we have previously validated the accuracy of our imputation pipeline for rare and common variants7,
we focused our validation efforts on the DNM set.
Family relationship conﬁrmation
There were reported 3,056 mother-child and 2,473 father-child connections among our 14,688 sequenced
Icelanders (over 20X average coverage) as recorded in the genealogical database, of those we conﬁrmed
2,981 and 2,386 based on haplotype sharing, respectively. This resulted in 1,548 trios and 225 three-
generation families after restricting the analysis to probands passing the quality control.
Three-generation set
We calibrated the cutoffs of our DNM calls via consistent segregation of alleles in three-generation
families. We used consistent transmission as the dependent variable in a generalized additive model
(GAM). We used the ﬁtted GAM model to derive prediction for all the DNM candidates. A histogram of
the prediction for all DNM candidates is shown in Fig. 2. There is a clean separation between variants
that we predicted to have been transmitted to the next generation and those that are inconsistent with
three-generation haplotype sharing.
Concordance among monozygotic twins
Only 8 of the 91 monozygotic twin probands were used for the DNM calling calibration. Thus, DNM
concordance among the monozygotic twins serves as an independent validation metric of the DNM calls.
We calculated the DNM discordance between each monozygotic twin proband and its monozygotic twin.
We treated all genotype calls of the monozygotic twin as missing if the depth was less than 10 and
heterozygous calls as missing if they did not meet the following requirements: at least 2 reads supporting
an alternative allele and allelic balance over or equal to 0.1. We could verify the absence or presence of the
genotype in the twin of the proband for 6,000 out of 6,034 DNMs and found low discordance (2.9%) for
the high quality DNMs calls (Fig. 3). This shows that our DNM data set is of high quality genome-wide as
there is no ascertainment of DNMs selected for validation beyond the monozygotic proband requirement.
Phase comparison
We used two complementary approaches to assign parent of origin to the DNMs, the haplotype sharing
between the parents and offspring of three-generation proband, and physically linking DNM candidates
with phased variants via read pair tracing. We compared the concordance and discrepancy between the
phasing methods. We found a low discrepancy 1.16% between the phasing approaches (Table 6).
Figure 3. The fraction of discordant DNMs between MZ twins. There were used 91 monozygotic twin pairs
for the discordance calculation. The discordance fraction was calculated as the fraction of the proband’s high
quality DNMs not found in the MZ twin.
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